Federal Register / Vol. 66, No. 30 / Tuesday, February 13, 2001 / Notices 10031

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Develop Methods for Gathering Data and

Completing Social Network Analysis in Drug

Abuse Prevention’’.

Date: February 15, 2001.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Gaithersburg Marriott

Washingtonian Center, 9751 Washingtonian

Boulevard, Gaithersburg, MD 20878.

Contact Person: Lyle Furr, Contract Review

Specialist, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 435–1439.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Prevention Training’’.

Date: March 1, 2001.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Gaithersburg Marriott

Washingtonian Center, 9751 Washingtonian

Boulevard, Gaithersburg, MD 20878.

Contact Person: Lyle Furr, Contract Review

Specialist, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 435–1439.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: February 6, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3599 Filed 2–12–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in section 552b(c)(4)

and 552b(c)(6), Title 5 U.S.C., as

amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel Services

Research on NIDA Treatment CTN.

Date: March 2, 2001.

Time: 8:30 a.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Kesinee Nimit, MD, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, Msc

041 9547, Bethesda, MD 20892–9547, (301)

435–1432.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

Programs Projects.

Date: March 20, 2001.

Time: 9 a.m. to 2 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Khursheed Asghar, PhD,

Chief, Basic Sciences Review Branch, Office

of Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, MSC

9547, Bethesda, MD 20892–9547, (301) 443–

2620.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: February 6, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3600 Filed 2–12–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Amended Notice of Meeting

Notice is hereby given of a change in

the meeting of the Treatment Research

Subcommittee, February 28, 2001, 10

a.m. to February 28, 2001, 6 p.m.,

Embassy Suites at the Chevy Chase

Pavilion, 4300 Military Road, N.W.,

Washington, DC, 20015 which was

published in the Federal Register on

January 26, 2001, Volume 66 FR 7923–

24.

The date of this meeting has been

changed to February 28–March 1, 2001.

The Committee will convene from 10

a.m. to 6 p.m. on February 28, and from

8:30 a.m. to 1 p.m. on March 1. The

meeting is closed to the public.

Dated: February 6, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3601 Filed 2–12–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 15, 2001.

Time: 12:30 p.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Four Point Sheraton, 1201 K Street,

N.W., Washington, DC 20005.

Contact Person: Priscilla B. Chen, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4104,

10032 Federal Register / Vol. 66, No. 30 / Tuesday, February 13, 2001 / Notices

MSC 7814, Bethesda, MD 20892, (301) 435–

1787.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Cardiovascular

Sciences Integrated Review Group.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gordon L. Johnson, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4136,

MSC 7802, Bethesda, MD 20892, (301) 435–

1212, johnsong@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Integrative,

Functional and Cognitive Neuroscience

Integrated Review Group Alcohol and

Toxicology Subcommittee 3.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Washington Monarch Hotel, 2401 M

Street, NW., Washington, DC 20037.

Contact Person: Christine Melchior, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4102,

MSC 7816, Bethesda, MD 20892, (301) 435–

1713.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Cardiovascular

Sciences Integrated Review Group,

Cardiovascular and Renal Study Section.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Suites, 1000 29th St.,

NW., Washington, DC 20007.

Contact Person: Russell T. Dowell, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Dr., Rm 2180, MSC

7818, Bethesda, MD 20892, (301) 435–1169,

dowellr@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Nadarajen A. Vydelingum,

PhD, Scientific Review Administrator,

Special Study Section—8, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, MSC 7854, Rm

5122, Bethesda, MD 20892, (301) 435–1176,

vydelinn@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Dharam S. Dhindsa, DVM,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5126,

MSC 7854, Bethesda, MD 20892, (301) 435–

1174, dhindsad@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Infectious Diseases

and Microbiology Integrated Review Group

Experimental Virology Study Section.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Robert Freund, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4198,

MSC 7808, Bethesda, MD 20892, 301–435–

1050, freundr@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, Chevy Chase

Pavilion, 4300 Military Rd., Wisconsin at

Western Ave., Washington, DC 20015.

Contact Person: Michael A. Lang, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5210,

MSC 7850, Bethesda, MD 20892, (301) 435–

1265.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: The River Inn, 924 25th Street,

Washington, DC 20037.

Contact Person: Gloria B. Levin, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435–

1017, leving@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Biophysical and

Chemical Sciences Integrated Review Group

Physical Biochemistry Study Section.

Date: February 26–27, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gopa Rakhit, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4154,

MSC 7806, Bethesda, MD 20892, (301) 435–

1721, rakhitg@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Social Sciences,

Nursing, Epidemiology and Methods

Integrated Review Group Nursing Research

Study Section.

Date: February 26–28, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Silver Spring, 8777

Georgia Avenue, Silver Spring, MD 20910.

Contact Person: Gertrude McFarland,

DNSC, FAAN, Scientific Review

Administrator, Center for Scientific Review,

National Institutes of Health, 6701 Rockledge

Drive, Room 4110, MSC 7816, Bethesda, MD

20892, (301) 435–1784.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Michael Micklin, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Oncological Sciences

Integrated Review Group Experimental

Therapeutics Subcommittee 2.

Date: February 26–28, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, Chevy Chase

Pavilion, 4300 Military Rd., Wisconsin at

Western Ave., Washington, DC 20015.

Federal Register / Vol. 66, No. 30 / Tuesday, February 13, 2001 / Notices 10033

Contact Person: Marcia Litwack, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4150,

MSC 7804, Bethesda, MD 20892, (301) 435–

1719

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Endocrinology and

Reproductive Sciences Integrated Review

Group Reproductive Biology Study Section.

Date: February 26–27, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Dennis Leszczynski, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 6170,

MSC 7892, Bethesda, MD 20892, (301) 435–

1044.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26–27, 2001.

Time: 9 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: Cheri Wiggs, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3180,

MSC 7848, Bethesda, MD 20892, (301) 435–

1261.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 26, 2001.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Lee Rosen, PhD, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 5116, MSC 7854,

Bethesda, MD 20892, (301) 435–1171.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Pathophysiological

Sciences Integrated Review Group Lung

Biology and Pathology Study Section.

Date: February 27–28, 2001.

Time: 8 a.m. to 7 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hilton Garden Inn, Washington, DC

Franklin Square, 815 14th Street, NW.,

Washington, DC 20005.

Contact Person: George M. Barnas, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2180,

MSC 7818, Bethesda, MD 20892, (301) 435–

0696, george_barnas@nih.gov

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 28, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Gaithersburg, 2

Montgomery Village Avenue, Gaithersburg,

MD 20879.

Contact Person: Gopal C. Sharma, DVM,

MS, PhD, Diplomate American Board of

Toxicology, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 2184 MSC 7818, Bethesda, MD 20892,

(301) 435–1783, sharmag@csr.nih.gov

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 28, 2001.

Time: 8 a.m. to 9 a.m.

Agenda: To review and evaluate grant

applications.

Place: Hilton Garden Inn, Washington, DC

Franklin Square, 815 14th Street, NW.,

Washington, DC 20005.

Contact Person: Everett E. Sinnett, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2178,

MSC 7818, Bethesda, MD 20892, (301) 435–

1016, sinnett@nih.gov

Name of Committee: Infectious Diseases

and Microbiology Integrated Review Group

Microbial Physiology and Genetics

Subcommittee 1.

Date: February 28–March 1, 2001.

Time: 8:30 a.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle, 1

Washington Circle, NW., Washington, DC

20037.

Contact Person: Martin L. Slater, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4184,

MSC 7808, Bethesda, MD 20892, 301 435–

1149.

Name of Committee: Oncological Sciences

Integrated Review Group Radiation Study

Section.

Date: February 28–March 2, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Watergate Hotel, 2650 Virginia

Ave, NW., Washington, DC 20037.

Contact Person: Paul K. Strudler, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4100,

MSC 7804, Bethesda, MD 20892, (301) 435–

1716.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 28–March 1, 2001.

Time: 6 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Monarch Hotel, 2400 M Street, NW.,

Washington, DC 20037.

Contact Person: David L. Simpson, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5192

MSC 7846, Bethesda, MD 20892, (301) 435–

1278.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 1, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1177, bunnagb@csr.nih.gov

Name of Committee: Cardiovascular

Sciences Integrated Review Group

Pharmacology Study Section.

Date: March 1–2, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20853.

Contact Person: Jeanne N. Ketley, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4130

MSC 7814, Bethesda, MD 20892, (301) 435–

1789.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 1–2, 2001.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, Fortune

Room, 2101 Wisconsin Avenue, NW.,

Washington, DC 20007.

Contact Person: Syed Quadri, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4144,

MSC 7804, Bethesda, MD 20892, (301) 435–

1211.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 1–2, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Grand Westin Hotel, 2350 M Street,

NW., Washington, DC 20037–1417.

Contact Person: Marjam G. Behar, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4178,

MSC 7806, Bethesda, MD 20892, (301) 435–

1180.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 1–2, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Clarion Hampshire Hotel, 1310 New

Hampshire Ave, NW., Washington, DC

20036.

Contact Person: Jay Joshi, PhD, Scientific

Review Administrator, Center for Scientific

10034 Federal Register / Vol. 66, No. 30 / Tuesday, February 13, 2001 / Notices

Review, National Institutes of Health, 6701

Rockledge Drive, Room 5184, MSC 7846,

Bethesda, MD 20892, (301) 435–1184.

Name of Committee: Cell Development and

Function Integrated Review Group Cell

Development and Function 6.

Date: March 1–2, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20852.

Contact Person: Richard D. Rodewald,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, Room 5142, MSC 7840, 6701

Rockledge Drive, Bethesda, MD 20892, (301)

435–1024, rodewalr@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 1–2, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Virginian Suites, 1500

Arlington Blvd., Arlington, VA 22209.

Contact Person: Karen Sirocco, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3184,

MSC 7848, Bethesda, MD 20892, 301 435–

0676, siroccok@csr.nih.gov

Name of Committee: Biophysical and

Chemical Sciences Integrated Review Group

Bio-Organic and Natural Products Chemistry

Study Section.

Date: March 1–2, 2001.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Silver Spring, 8777

Georgia Avenue, Silver Spring, MD 20910.

Contact Person: Mike Radtke, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4176,

MSC 7806, Bethesda, MD 20892, 301 435–

1728, radtkem@csr.nih.gov

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 2, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124,

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1177, bunnagb@csr.nih.gov

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 2, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Luigi Giacometti, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5208,

MSC 7850, Bethesda, MD 20892, (301) 435–

1246.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 2, 2001.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Lee S. Mann, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3186,

MSC 7848, Bethesda, MD 20892, (301) 435–

0677.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: February 6, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3595 Filed 2–12–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4491–N–05]

Notice of Draft Environmental Impact

Statement: City of Hartford, CT;

Section 108 Loan Guarantee/BEDI

Grant

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Notice.

SUMMARY: The Department of Housing

and Urban Development gives this

notice to the public that the City of

Hartford, Connecticut intends to prepare

an Environmental Impact Statement

(EIS) for the Adriaen’s Landing Project.

This Notice is in accordance with

regulations of the Council on

Environmental Quality as described in

40 CFR parts 1500–1508. Federal

agencies having jurisdiction by law,

special expertise, or other special

interest should report their interests and

indicate their readiness to aid in the EIS

effort as a ‘‘Cooperating Agency.’’

A Draft EIS will be completed for the

proposed action described herein.

Comments relating to the Draft EIS are

requested and will be accepted by the

contact person listed below. When the

Draft EIS is completed, a notice will be

sent to individuals and groups known to

have an interest in the Draft EIS and

particularly in the environmental

impact issues identified therein. Any

person or agency interested in receiving

a notice and making comment on the

Draft EIS should contact the person

listed below within 45 days after the

publication of this Notice.

ADDRESSES: All interested agencies,

groups and persons are invited to

submit written comments on the withinnamed project and the Draft EIS to the

following contact person. Such

comments should be received by the

office of the contact person and all

comments so received will be

considered prior to the preparation and

distribution of the Draft EIS.

Particularly solicited is information

on reports or other environmental

studies planned or completed in the

project area, major issues and dates

which the EIS should consider and

recommended mitigating measures and

alternatives associated with the

proposed project. Federal agencies

having jurisdiction by law, special

expertise or other special interest

should report their interests and

indicate their readiness to aid the EIS

effort as a ‘‘cooperating agency.’’

FOR FURTHER INFORMATION CONTACT:

Dennis J. Johnson, Contract Manager,

City of Hartford, Division of

Management & Budget, Office of Grants

Management, Room 108, 550 Main

Street, Hartford, CT, 06103. Telephone:

(860) 543–8650.

SUPPLEMENTARY INFORMATION:

A: Background

The City of Hartford, acting under

authority of section 104(g) of the

Housing and Community Development

Act of 1974 (42 U.S.C. 5304(g)) and

HUD’s regulations at 24 CFR part 58, in

cooperation with the Capital City

Economic Development Authority, the

Federal Highway Administration, and

other interested agencies, will prepare

an Environmental Impact Statement

(EIS) to analyze potential impacts of

constructing a 33-acre mixed use

development complex including: (1) A

retail/entertainment venue of a

maximum of approximately 265,000

square feet, (2) an approximately

500,000 square feet convention center,

(3) an approximately 700-room

convention center hotel, (4)

approximately 200 to 400 residential

apartments, (5) an approximately

200,000 square feet future attraction

(public interactive-entertainment and

education venue), (6) parking facilities

representing approximately 6,000

spaces, and (7) relocation and

modification of sewer, water, and other

utility infrastructure and vehicular and

pedestrian traffic access modifications.

Adriaen’s Landing will be located in

downtown Hartford along the

Connecticut River. The estimated cost

for this project is 650 million dollars.